BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35228179)

  • 21. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
    Zhang YZ; Liu HL; He QS; Xu Z
    Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease.
    Menteşe E; Bektaş H; Sokmen BB; Emirik M; Çakır D; Kahveci B
    Bioorg Med Chem Lett; 2017 Jul; 27(13):3014-3018. PubMed ID: 28526368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Antioxidant and In-Silico Studies of Potent Urease Inhibitors: N-(4-{[(4-Methoxyphenethyl)-(substituted)amino]sulfonyl}phenyl)acetamides.
    Abbasi MA; Raza H; Rehman AU; Siddiqui SZ; Nazir M; Mumtaz A; Shah SAA; Seo SY; Hassan M
    Drug Res (Stuttg); 2019 Feb; 69(2):111-120. PubMed ID: 30086567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syntheses, in vitro urease inhibitory activities of urea and thiourea derivatives of tryptamine, their molecular docking and cytotoxic studies.
    Kanwal ; Khan M; Arshia ; Khan KM; Parveen S; Shaikh M; Fatima N; Choudhary MI
    Bioorg Chem; 2019 Mar; 83():595-610. PubMed ID: 30513472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, antimicrobial, antioxidant, cytotoxic, antiurease and molecular docking studies of N-(3-trifluoromethyl)benzoyl-N'-aryl thiourea derivatives.
    Maalik A; Rahim H; Saleem M; Fatima N; Rauf A; Wadood A; Malik MI; Ahmed A; Rafique H; Zafar MN; Riaz M; Rasheed L; Mumtaz A
    Bioorg Chem; 2019 Jul; 88():102946. PubMed ID: 31054433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and docking studies of novel 1,2-dihydro-4-hydroxy-2-oxoquinoline-3-carboxamide derivatives as a potential anti-proliferative agents.
    Banu S; Bollu R; Bantu R; Nagarapu L; Polepalli S; Jain N; Vangala R; Manga V
    Eur J Med Chem; 2017 Jan; 125():400-410. PubMed ID: 27688193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents.
    Rono CK; Darkwa J; Meyer D; Makhubela BCE
    Curr Org Synth; 2019; 16(6):900-912. PubMed ID: 31984911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzimidazolone-piperazine/triazole/thiadiazole/furan/thiophene conjugates: Synthesis, in vitro urease inhibition, and in silico molecular docking studies.
    Güven O; Menteşe E; Emirik M; Sökmen BB; Akyüz G
    Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300336. PubMed ID: 37612782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antitumor activity studies of some new fused 1,2,4-triazole derivatives carrying 2,4-dichloro-5-fluorophenyl moiety.
    Bhat KS; Poojary B; Prasad DJ; Naik P; Holla BS
    Eur J Med Chem; 2009 Dec; 44(12):5066-70. PubMed ID: 19822384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and CYP26A1 inhibitory activity of 1-[benzofuran-2-yl-(4-alkyl/aryl-phenyl)-methyl]-1H-triazoles.
    Pautus S; Yee SW; Jayne M; Coogan MP; Simons C
    Bioorg Med Chem; 2006 Jun; 14(11):3643-53. PubMed ID: 16458519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, in vitro urease inhibition and molecular docking studies of some novel quinazolin-4(3H)-one derivatives containing triazole, thiadiazole and thiosemicarbazide functionalities.
    Menteşe E; Akyüz G; Emirik M; Baltaş N
    Bioorg Chem; 2019 Mar; 83():289-296. PubMed ID: 30391701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells.
    Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA
    Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of 4H-3-(2-phenoxy)phenyl-1,2,4-triazole derivatives as benzodiazepine receptor agonists.
    Akbarzadeh T; Tabatabai SA; Khoshnoud MJ; Shafaghi B; Shafiee A
    Bioorg Med Chem; 2003 Mar; 11(5):769-73. PubMed ID: 12538007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities.
    El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
    Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and SAR exploration of tri-substituted 1,2,4-triazoles as inhibitors of the annexin A2-S100A10 protein interaction.
    Reddy TR; Li C; Guo X; Fischer PM; Dekker LV
    Bioorg Med Chem; 2014 Oct; 22(19):5378-91. PubMed ID: 25172147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of substituted-phenyl-1,2,4-triazol-3-thione analogues with modified D-glucopyranosyl residues and their antiproliferative activities.
    Li Z; Gu Z; Yin K; Zhang R; Deng Q; Xiang J
    Eur J Med Chem; 2009 Nov; 44(11):4716-20. PubMed ID: 19560842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel 1,2,4-triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studies.
    Turky A; Sherbiny FF; Bayoumi AH; Ahmed HEA; Abulkhair HS
    Arch Pharm (Weinheim); 2020 Dec; 353(12):e2000170. PubMed ID: 32893368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, molecular docking and synthesis of novel 5,6-dichloro-2-methyl-1H-benzimidazole derivatives as potential urease enzyme inhibitors.
    Menteşe E; Emirik M; Sökmen BB
    Bioorg Chem; 2019 May; 86():151-158. PubMed ID: 30710848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conventional versus microwave assisted synthesis, molecular docking and enzyme inhibitory activities of new 3,4,5-trisubstituted-1,2,4-triazole analogues.
    Virk NA; Rehman A; Abbasi MA; Siddiqui SZ; Rashid U; Iqbal J; Saleem M; Ashraf M; Shahid W; Shah SAA
    Pak J Pharm Sci; 2018 Jul; 31(4(Supplementary)):1501-1510. PubMed ID: 30058542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.
    Barbuceanu SF; Almajan GL; Saramet I; Draghici C; Tarcomnicu AI; Bancescu G
    Eur J Med Chem; 2009 Nov; 44(11):4752-7. PubMed ID: 19616347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.